Midas's 3Q13 net profit topped our expectations by a mile on the back of robust sales and the strong contribution from Midas's associate, NPRT. Things are also looking brighter for its balance sheet, with inventory days and receivable days falling to one-year lows.
Midas's 9M13 net profit was above our expectation, at 80% of our FY13 forecast. We raise FY13 EPS by 45% as we expect stronger earnings growth in 4Q13 from the recognition of new HSR contracts. However, we cut FY14-15 EPS by 4-6% for higher finance costs. Maintain Outperform and target price of $0.74, based on 1.29x CY14 P/BV (20% discount to average P/BV during 2010-11). New HSR contract wins is the key catalyst.
Read more »